Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 564-571

  Stojakovic, Tatjana ^a   Scharnagl, Hubert ^a   Trauner, Michael ^a   Pieske, Burkert ^a   Wellnitz, Britta ^b   Seelhorst, Ursula ^b   Schilling, Dieter ^c   Winkelmann, Bernhard R ^d   Boehm, Bernhard O ^e   März, Winfried ^a,f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LURIC Study Nonprofit LLC   (Germany)

^c Diakonie Hospital Mannheim   (Germany)

^d Cardiology Group Frankfurt Sachsenhausen   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f SYNLAB ACADEMY   (Germany)

Author keywords

Cardiovascular disease; Gamma glutamyl transferase; Mortality; Risk factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN T;

ACUTE CORONARY SYNDROME; AGING; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; TIME FACTORS;

EID: 74749097438     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.07.026     Document Type: Article

References (40)

1. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38 (2001) 263-355
2. Teschke R., Brand A., and Strohmeyer G. Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun 75 (1977) 718-724
3. Anderson M.E., Allison R.D., and Meister A. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Proc Natl Acad Sci USA 79 (1982) 1088-1091
4. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 47 (1999) 151-160
5. Paolicchi A., Emdin M., Passino C., et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186 (2006) 80-85
6. Emdin M., Pompella A., Paolicchi A., and Gamma-glutamyltransferase. atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112 (2005) 2078-2080
7. Paolicchi A., Emdin M., Ghliozeni E., et al. Images in cardiovascular medicine, human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109 (2004) 1440
8. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
9. Loria P., Lonardo A., Bellentani S., et al. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis 17 (2007) 684-698
10. Targher G., and Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 191 (2007) 235-240
11. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 24 (2007) 1-6
12. Fraser A., Ebrahim S., Davey Smith G., and Lawlor D.A. A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology 46 (2007) 158-165
13. Hanley A.J., Wagenknecht L.E., Festa A., D'Agostino Jr. R.B., and Haffner S.M. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 30 (2007) 1819-1827
14. Emdin M., Passino C., Michelassi C., et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 22 (2001) 1802-1807
15. Karlson B.W., Wiklund O., Hallgren P., et al. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 247 (2000) 449-456
16. Wannamethee G., Ebrahim S., and Shaper A.G. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 142 (1995) 699-708
17. Lee D.H., Silventoinen K., Hu G., et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27 (2006) 2170-2176
18. Lee D.S., Evans J.C., Robins S.J., et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
19. Meisinger C., Doring A., Schneider A., and Lowel H. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189 (2006) 297-302
20. Ruhl C.E., and Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 136 (2009) 477-485 e11
21. Ruttmann E., Brant L.J., Concin H., et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112 (2005) 2130-2137
22. Strasak A.M., Kelleher C.C., Klenk J., et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol 28 (2008) 1857-1865
23. Wannamethee S.G., Lennon L., and Shaper A.G. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis (2008)
24. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2 (2001) S1-73
25. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486-2497
26. Bachorik P.S., and Ross J.W. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on lipoprotein measurement. Clin Chem 41 (1995) 1414-1420
27. Wanner C., Horl W.H., Luley C.H., and Wieland H. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 39 (1991) 754-760
28. Andre P., Balkau B., Vol S., Charles M.A., and Eschwege E. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: data from the epidemiological study on the insulin resistance syndrome (DESIR) cohort. Diabetes Care 30 (2007) 2355-2361
29. Giral P., Jacob N., Dourmap C., et al. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 28 (2008) 587-593
30. Saely C.H., Vonbank A., Rein P., et al. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. Clin Chim Acta 397 (2008) 82-86
31. Wannamethee S.G., Shaper A.G., Lennon L., and Whincup P.H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28 (2005) 2913-2918
32. Ford E.S., Schulze M.B., Bergmann M.M., et al. Liver enzymes and incident diabetes: findings from the European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Diabetes Care 31 (2008) 1138-1143
33. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535-539
34. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
35. Ryu S., Chang Y., Kim D.I., Kim W.S., and Suh B.S. γ-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53 (2007) 71-77
36. Lim J.S., Lee D.H., Park J.Y., Jin S.H., and Jacobs Jr. D.R. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 53 (2007) 1092-1098
37. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
38. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
39. Lee D.H., and Jacobs Jr. D.R. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178 (2005) 327-330
40. Tuzcu E.M., Kapadia S.R., Tutar E., et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103 (2001) 2705-2710